These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

274 related articles for article (PubMed ID: 28042707)

  • 1. Clinical experience with drug delivery systems as tools to decrease the toxicity of anticancer chemotherapeutic agents.
    Maranhão RC; Vital CG; Tavoni TM; Graziani SR
    Expert Opin Drug Deliv; 2017 Oct; 14(10):1217-1226. PubMed ID: 28042707
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Advanced targeted therapies in cancer: Drug nanocarriers, the future of chemotherapy.
    Pérez-Herrero E; Fernández-Medarde A
    Eur J Pharm Biopharm; 2015 Jun; 93():52-79. PubMed ID: 25813885
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Passive and active targeting in cancer therapy by liposomes and lipid nanoparticles.
    Alavi M; Hamidi M
    Drug Metab Pers Ther; 2019 Feb; 34(1):. PubMed ID: 30707682
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reduction of Atherosclerotic Lesions by the Chemotherapeutic Agent Carmustine Associated to Lipid Nanoparticles.
    Daminelli EN; Martinelli AE; Bulgarelli A; Freitas FR; Maranhão RC
    Cardiovasc Drugs Ther; 2016 Oct; 30(5):433-443. PubMed ID: 27628679
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Advances in non-invasive drug delivery for atherosclerotic heart disease.
    Maranhão RC; Tavares ER
    Expert Opin Drug Deliv; 2015 Jul; 12(7):1135-47. PubMed ID: 25585820
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lipid-based drug delivery systems for cancer treatment.
    Arias JL; Clares B; Morales ME; Gallardo V; Ruiz MA
    Curr Drug Targets; 2011 Jul; 12(8):1151-65. PubMed ID: 21443475
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Active targeting strategies for anticancer drug nanocarriers.
    Basile L; Pignatello R; Passirani C
    Curr Drug Deliv; 2012 May; 9(3):255-68. PubMed ID: 22452402
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel formulation of a methotrexate derivative with a lipid nanoemulsion.
    Moura JA; Valduga CJ; Tavares ER; Kretzer IF; Maria DA; Maranhão RC
    Int J Nanomedicine; 2011; 6():2285-95. PubMed ID: 22072866
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tumor-targeted delivery of paclitaxel using low density lipoprotein-mimetic solid lipid nanoparticles.
    Kim JH; Kim Y; Bae KH; Park TG; Lee JH; Park K
    Mol Pharm; 2015 Apr; 12(4):1230-41. PubMed ID: 25686010
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeted thermosensitive liposomes: an attractive novel approach for increased drug delivery to solid tumors.
    Dicheva BM; Koning GA
    Expert Opin Drug Deliv; 2014 Jan; 11(1):83-100. PubMed ID: 24320104
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The use of ultrasound to release chemotherapeutic drugs from micelles and liposomes.
    Ahmed SE; Martins AM; Husseini GA
    J Drug Target; 2015 Jan; 23(1):16-42. PubMed ID: 25203857
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The achievement of ligand-functionalized organic/polymeric nanoparticles for treating multidrug resistant cancer.
    Lee WH; Loo CY; Leong CR; Young PM; Traini D; Rohanizadeh R
    Expert Opin Drug Deliv; 2017 Aug; 14(8):937-957. PubMed ID: 27759437
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Organic effects of associating paclitaxel with a lipid-based nanoparticle system on a nonhuman primate,
    Feio DCA; de Oliveira NCL; Pereira ELR; Morikawa AT; Muniz JAPC; Montenegro RC; Alves APNN; de Lima PDL; Maranhão RC; Burbano RR
    Int J Nanomedicine; 2017; 12():3827-3837. PubMed ID: 28572727
    [TBL] [Abstract][Full Text] [Related]  

  • 14. General overview of lipid-polymer hybrid nanoparticles, dendrimers, micelles, liposomes, spongosomes and cubosomes.
    Wakaskar RR
    J Drug Target; 2018 Apr; 26(4):311-318. PubMed ID: 28797169
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hydrophobic ion pairing as a strategy to improve drug encapsulation into lipid nanocarriers for the cancer treatment.
    Oliveira MS; Goulart GCA; Ferreira LAM; Carneiro G
    Expert Opin Drug Deliv; 2017 Aug; 14(8):983-995. PubMed ID: 27892713
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chemotherapy with anticancer drugs encapsulated in solid lipid nanoparticles.
    Wong HL; Bendayan R; Rauth AM; Li Y; Wu XY
    Adv Drug Deliv Rev; 2007 Jul; 59(6):491-504. PubMed ID: 17532091
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nanoparticles as delivery carriers for anticancer prodrugs.
    Fang JY; Al-Suwayeh SA
    Expert Opin Drug Deliv; 2012 Jun; 9(6):657-69. PubMed ID: 22507134
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Liposomes and nanoparticles: nanosized vehicles for drug delivery in cancer.
    Malam Y; Loizidou M; Seifalian AM
    Trends Pharmacol Sci; 2009 Nov; 30(11):592-9. PubMed ID: 19837467
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lipid nanoparticles for chemotherapeutic applications: strategies to improve anticancer efficacy.
    Lin X; Gao R; Zhang Y; Qi N; Zhang Y; Zhang K; He H; Tang X
    Expert Opin Drug Deliv; 2012 Jul; 9(7):767-81. PubMed ID: 22554018
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recent advances in polymeric micelles for anti-cancer drug delivery.
    Biswas S; Kumari P; Lakhani PM; Ghosh B
    Eur J Pharm Sci; 2016 Feb; 83():184-202. PubMed ID: 26747018
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.